Ireland
--:--IST
Enrolling by invitation Not applicable

Impact of Inspiratory Muscle Training (IMT) With Intermittent Variable Resistance (IVR) Versus Constant Resistance (CR) on Functional Capacity in Lung Transplantation (LTx) Patients (I-TRAIN-LTx Study)

NCT06963190 · tracked via the Priya Life Science Spain tracker
Sponsor
Hospital Universitario Marqués de Valdecilla
Phase
Not applicable
Started
2025-08-31
Last updated
2025-09-08

Condition(s) studied

Lung Transplantation

Investigational drug(s) / intervention(s)

Constant Resistance (CR)Intermittent Variable Resistance (IVR)

Constant Resistance (CR): Will perform inspiratory muscle training at 30% of MIP. Two daily sessions of 30 breaths or 10 minutes.

Intermittent Variable Resistance (IVR): Will perform inspiratory muscle training at 30% of MIP. This will consist of two daily sessions of 30 breaths or 10 minutes. Additionally, the participant will complete 8 sets of 3 repetitions at 60% of the MIP, distributed throughout the day, with a one-minute rest between each repetition.

Study summary

\- Objectives: Primary Objective: To compare Maximum Inspiratory Pressure (MIP) in lung transplant (LT) patients between the use of inspiratory muscle training (IMT) with intermittent variable resistance (IVR) or constant resistance (CR) during the first six months post-transplant.

Secondary Objectives: To determine whether there are differences in the outcomes of IMT with IVR and IMT with CR in the six-minute walk test, spirometry values, and arterial blood gas analysis within the first six months post-transplant.

To analyze the influence of relevant clinical conditions on dependent variables in both groups: duration of mechanical ventilation during the immediate postoperative period of LT and presence of diaphragmatic paralysis.

To analyze the proportion of patients with Baseline Lung Allograft Dysfunction (BLAD) in both intervention groups.

\- Methodology: Design: Open-label, two-arm, randomized clinical trial.

Intervention: Random allocation into:

CR Group: Will perform IMT at 30% of MIP. IVR Group: Will perform IMT at 30% and 60% of MIP.

Population and Sample: Patients undergoing lung transplantation.

Demographic and LT-related variables: Sex, date of birth, height, weight, body mass index, type of transplant, underlying disease leading to transplantation, phrenic paralysis, length of stay in the intensive care unit, days on mechanical ventilation, primary graft dysfunction, and acute rejection.

Dependent Variables: MIP, spirometry, arterial blood gas analysis, six-minute walk test, and BLAD criteria.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patient (≥18 years) who has undergone lung transplantation (single-lung or double-lung) at our center. * Alert and cooperative (Glasgow Coma Scale \>13 points). * Hemodynamically stable (blood pressure between 90/60 and 165/90 mmHg; heart rate between 60 and 130 beats per minute). * No disabling dyspnea at rest (maintained at mild levels according to the Borg scale or NYHA class I-II), even if requiring supplemental oxygen with a saturation \>89%. * No limiting chest pain interfering with respiratory therapy. Exclusion Criteria: * Patients unable to cooperate with treatment due to lack of necessary instrumental cognitive skills. * Perceived non-adherence to pharmacological and non-pharmacological treatment by healthcare personnel. * Need for continuous non-invasive mechanical ventilation, high-flow oxygen therapy, or Venturi mask. * Patients with significant neurological disorders, severe polyneuropathies, or stroke (CVA). * Presence of tracheostomy, active hemoptysis, bronchial suture dehiscence. * Significant air leak with clinical repercussions. * Any clinical condition that, in the investigator's judgment, poses a risk to the patient.

Primary outcome measure(s)

  • Dependent variables — Measurements will be performed at the time of recruitment (baseline) and at months 1, 2, 4, and 6 post-transplant.
    Maximal inspiratory pressure: Expressed in cmH₂O.
  • Dependent variables — Measurements will be performed at the time of recruitment (baseline) and at months 1, 2, 4, and 6 post-transplant.
    Spirometry: Forced expiratory volume in the first second (FEV1) in mL and percentage of predicted, forced vital capacity (FVC) in mL and percentage, and FEV1/FVC ratio.

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario Marqués de Valdecilla Santander Cantabria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06963190 on ClinicalTrials.gov ↗ ← All trials in Spain